Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Construction in Progress (2022 - 2025)

Intelligent Bio Solutions has reported Construction in Progress over the past 3 years, most recently at $543410.0 for Q2 2024.

  • For Q2 2024, Construction in Progress fell 15.9% year-over-year to $543410.0; the TTM value through Jun 2024 reached $543410.0, down 15.9%, while the annual FY2024 figure was $543410.0, 15.9% down from the prior year.
  • Construction in Progress for Q2 2024 was $543410.0 at Intelligent Bio Solutions, down from $646116.0 in the prior quarter.
  • Over five years, Construction in Progress peaked at $832058.0 in Q3 2022 and troughed at $306792.0 in Q1 2022.
  • A 3-year average of $513571.6 and a median of $438304.0 in 2022 define the central range for Construction in Progress.
  • Biggest five-year swings in Construction in Progress: skyrocketed 65.07% in 2023 and later dropped 15.9% in 2024.
  • Year by year, Construction in Progress stood at $438304.0 in 2022, then soared by 47.41% to $646116.0 in 2023, then decreased by 15.9% to $543410.0 in 2024.
  • Business Quant data shows Construction in Progress for INBS at $543410.0 in Q2 2024, $646116.0 in Q2 2023, and $436913.0 in Q1 2023.